Metachronous Bilateral Testicular Mixed Germ Cell Neoplasm: A Case Report.
DOI:
https://doi.org/10.54212/27068048.v10i1.10Keywords:
Testicular tumor, Radical orchiectomy, Metachronous tumorAbstract
Introduction: Testicular tumors represent 1% of neoplasms in males, with the highest incidence between 15 and 35 years, 95% of them will be seminoma-type germ cells. 2% of patients can develop a bilateral tumor synchronously or metachronously, the latter occurs in most cases at 5 years, however it can present up to 10 years after the primary tumor. Objective: To present the clinical case of a patient with a metachronous mixed germ cell tumor developed 7 years after the primary tumor and its surgical management. Methods: Image studies and tumor markers are performed on the patient and he undergoes orchiectomy, reporting epididymis and spermatic cord without histological abnormalities, free of neoplasia, with adequate postoperative evolution and management with hormonal therapy. Conclusions: Treatment for a bilateral tumor, as well as a unilateral one, will depend on the histological type, the presence of metastases and the tumor markers, currently orchiectomy being the treatment of choice, accompanied by hormonal therapy or radiotherapy. Testicular tumors have an excellent prognosis even presenting in advanced stages, so strict follow-up is important after having treated a primary tumor.
Downloads
References
Herrera A., Granados M., Ñamendys S., Meneses A., Manual de Oncologia. Procedimientos médico quirúrgicos. 6ª edición. McGrawHill. Mexico DF, 2017 Cap. 76 Cáncer Testicular
American Cancer Society. Cancer Facts and Figures 2013. [Internet]. Dirección URL: [Consultado 6 sep 2021] Disponible en: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2013.html
Almazan A,, Rosas J., Berber A., Hernandez M.,Tumor testicular metacrónico 19 años después. Rev Mex Urol. 2014 May-Jun;74(3): 180-183 [internet] [consultado 9 sep] Disponible en: https://www.elsevier.es/es-revista-revista-mexicana-urologia-302-articulo-tumor-testicular-metacronico-19-anos-S2007408515300343 https://doi.org/10.1016/S2007-4085(15)30034-3 DOI: https://doi.org/10.1016/S2007-4085(15)30034-3
Hamilton JB, Gilbert JB. Studies in malignant tumors of the testis: bilateral testicular cancer incidence, nature, and bearing upon management of patients with single testicular cancer. Cancer Res. USA. [INTERNET] 1942 [Consultado 5 de sep 2021]1942; 2:125. Disponible en: https://cancerres.aacrjournals.org/content/canres/2/2/125.full.pdf
Albers P., Albrecht W. , Algaba C., Bokemeyer G., Cohn-Cedermark K. Guidelines on Testicular Cancer. European Society for Medical Oncology annual meeting. 27 sep-1 oct 2019. [internet] [consultado 9 sep ] Disponible en : https://www.urotoday.com/recent-abstracts/urologic-oncology/testicular-cancer/5201-guidelines-archive-3572.html
Arda, E., Cakiroglu, B., Cetin, G., & Yuksel, I. (2017). Metachronous Testicular Cancer After Orchiectomy: A Rare Case. Cureus, 9(11), e1833. https://doi.org/10.7759/cureus.1833 DOI: https://doi.org/10.7759/cureus.1833
American Cancer Society. Cancer Facts and Figures 2013. [Internet]. Dirección URL: [Consultado 6 sep 2021] Disponible en: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2013.html
Ávila A., Chávez G., Astigueta J. Cáncer de testículo bilateral metacrónico seminomatoso. Rev Cubana Urol, CUB [Internet] 2019. [Consultado 6 sep 2021] 2019;8(2):130-135 Disponible en: http://www.revurologia.sld.cu/index.php/rcu/article/view/475/601
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Stephanie Judith López Balcarcel, Gustavo Ricardo Tercero Cabrera, Hugo Roberto Barbales Irias, Marco Antonio Ortiz Herrera & Gustavo Eduardo González Reynoso
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
